Our Investments

Psych Capital includes the industry’s leading data and market intelligence platform(s).

Shortwave Pharma works to address the unmet medical needs of patients suffering from treatment resistant mental health and chronic conditions, with a particular focus on eating disorders.

PSYCH is a B2B media and intelligence platform for the psychedelic science and healthcare industry. It has quickly become the leading global resource for networking, insights and opportunities – powered by trustworthy data, independent analysis and engaging events that attract the largest B2B audience in the industry.

Awakn Life Sciences is a clinical biotech company researching, developing and delivering evidenced-based psychedelic medicine to treat addiction and other mental health conditions.

Blossom is the leading source for scientific and regulatory data for the psychedelics industry. Blossom is presently collaborating with PSYCH to build the industry’s first SAAS platform.

You X Psych Capital

Are you a founder with a strong track record in science, healthcare or business looking for pre-seed capital or to incubate a company in psychedelic healthcare?

Let’s Talk

Shortwave Pharma™

PSYCH™

Awakn™

Blossom

Unparalleled Insights. One Weekly Email. No Spam.

Unparalleled Insights. One Weekly Email. No Spam.